AstraZeneca plans to change drug distribution
The modification to the business, which could transform the way drugs are delivered in the UK, will mean that only one or two logistics companies will distribute its
Faeth Therapeutics has received the US Food and Drug Administration’s (FDA) fast track designation for the sapanisertib and serabelisib (PIKTOR) with paclitaxel combination to treat advanced or recurrent endometrial cancer.